From Discovery To Development To Delivery
AZBio is committed to building a top-tier life science industry in Arizona.
Arizona has a sizable and rapidly growing bioscience industry. State bioscience firms employed 25,686 in 2016 in 1,310 individual business establishments. Industry employment has grown by 9 percent since 2014, twice the growth rate of the nation, with four of the five major subsectors adding jobs during the period. Both drugs and pharmaceuticals and research, testing and medical labs have experienced double-digit job growth since 2014. Arizona inventors have been awarded nearly 2,000 bioscience-related patents since 2014, among the second quintile of states in patent activity. Since 2015, NIH awards to Arizona institutions have increased, reaching $189 million in FY 2017. (Get The Facts)
AZBio Members Are Making LIFE Bettter
AZBio Members discover, develop, and deliver life-saving and life-changing innovations.
Get Connected With Arizona's Bioindustry
A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on Arizona’s bioscience industry. AZBio membership includes patient advocacy organizations, life science innovators, educators, healthcare partners and leading business organizations. AZBio is the statewide affiliate of the Biotechnology Innovation Organization (BIO) and works in partnership with AdvaMed, MDMA, and PhRMA to advance innovation and to ensure that the value delivered from life-changing and life-saving innovation benefits people in Arizona and around the world.
Success Stories – Good News from Arizona’s BioIndustry
PRLog (Press Release) – Jul 23, 2012 – Diomics Mourns the Passing of Founder and CEO Jeff Morhet, Announces Forward Plans Diomics, a leading bioscience company focused on the development of Diomat™ technology for a range of life science, aerospace and specialty products, mourns the passing of Founder and CEO Jeff Morhet, and announces forward […]
Phoenix Biomedical Campus drives Growth in Education and Jobs
Each Sunday, BioCentury This Week focuses on key issues in the bioindustry. On Sunday July 22, 2012, the focus of the program zeroed in on the recent news from Washington on the FDA Investigation regarding “whistle blowers” and the protection of industry confidential information.
Patients should benefit from timely exchange of DNA sequencing results
- TENWEST Impact Festival
- 10/11/2019 - 10/20/2019
- TENWEST: Idea Funding
- BIO Investor Forum 2019
- 10/22/2019 - 10/23/2019
- San Francisco
- Women’s Angel Investor Forum
- Mini-Medical School - Flinn Foundation Buffmire Lecture